Dr. Abbas Ardehali, MD

Dr. Ardehali practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Ardehali's NPI, 1649205576, was assigned on July 11, 2006. Dr. Ardehali graduated from Emory School of Medicine in 1986. Dr. Ardehali's California license number on file is G62746.

Dr. Ardehali's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Ardehali's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Ardehali is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Cardiothoracic Surgery Associates. Dmand AI also links Dr. Ardehali to 3 more home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ardehali practices, 5 sites in all. Vendor and product names are available with a free account.

Thoracic surgery (cardiothoracic vascular surgery) is Dr. Ardehali's primary specialty in the NPI Registry, under taxonomy code 208G00000X. Dr. Ardehali is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Ardehali's licenses on file in 2 states: California and Texas.

Dmand AI lists heart bypass surgery and heart valve surgery among the conditions Dr. Ardehali treats.

CMS data shows 236 Medicare services from Dr. Ardehali across 7 procedure codes in 2024, for 124 Medicare patients. Medicare paid $51,714 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 124 Medicare patients who saw Dr. Ardehali in 2024. The largest group is 65 to 74, with 70 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 2.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ardehali's median patient age at 65, with 27% women.

In 2024, Dr. Ardehali wrote 14 Medicare Part D claims. 93% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $552 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Ardehali for performance year 2024, reported as part of a group. Dr. Ardehali accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 42 procedures of coronary artery bypass graft (cabg) by Dr. Ardehali, more than 93% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. Ardehali, published from 2008 to 2019. 2019 was the busiest year, with 4. Dr. Ardehali's most frequent co-authors are John A. Belperio, MD, Reshma M. Biniwale, MD and Mario Chih-Hsiung Karl Deng, MD.

Dmand AI links Dr. Ardehali to 6 clinical trials. 1 is still active or recruiting. Conditions studied include Heart Failure, Idiopathic Pulmonary Fibrosis and Primary Graft Dysfunction. TransMedics sponsors the most, 4.

CMS Open Payments shows 65 general payments to Dr. Ardehali from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 45% of the total. TransMedics, Inc. paid the most, $12,432. It also lists 101 research payments totaling $54,689 from 2016 to 2019.

Dmand AI lists 4 awards for Dr. Ardehali, most recently Top Doctors:LA Area in 2013.

Dr. Ardehali graduated from Emory School of Medicine in 1986. Dr. Ardehali is a member of ACS.

Dr. Ardehali is in network with 7 carriers, including Blue Cross Blue Shield of Michigan, Elevance and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.